Cells were differentiated according to the protocol described by Hazim et al. (20 (link)). Briefly, cells were cultivated in T75 flask for two weeks with MEM-nicotinamide medium: 1% N1 (Invitrogen), 1% SVFi, 1% P/S, 0.25mg/mL Taurine (Sigma-Aldrich), Hydrocortisone 20ng/mL (Sigma-Aldrich), Triiodo-thyronine 0.013 ng/mL (Sigma-Aldrich) and 10mM nicotinamide (Sigma-Aldrich). After 3 times 10min TrypLE (Gibco) treatment, the remaining cells were placed on 0.4µM PET transwell inserts (Falcon, 353095) in 24-well-plates, coated with natural mouse laminin (Invitrogen). Cell medium was changed 3 times per week during 8 weeks before use. Differentiation was verified using RT-PCR analysis of markers indicating primary like cell phenotype. Cells on transwells were harvested every week during 8 weeks using Nucleozol (Macherey-Nagel, MN). RNA was extracted with TriZol reagent, according to the manufacturer’s recommendations. Then, 20ng of RNA was reverse transcribed to cDNA using Qscript reagent (VWR). Real-time PCR specific for the BEST1, RPE65, OCLN, MERTK, ZO-1, ITGB5 and housekeeping gene GAPDH mRNA (Table 1) was performed on CFX light cycler and SSoAdvanced SybrGreen (Biorad).
Free full text: Click here